2024 CBIIC in Guangzhou on November 30 - December 2, 2024.
Doctor of Pharmacy, doctoral tutor, chief pharmacist of Beijing Hospital Pharmacy Department. The research direction is the research of new pharmacokinetic methods and key technologies of Chinese and western medicines; the research of pharmacokinetics of drug interactions; the research of drug clinical pathway; the research of hospital drug safety vigilance. Over the years, he has published more than 100 papers, completed more than 50 clinical studies of new drugs, and formulated a number of new drug quality standards (including the separation of chiral drugs, the determination of cis-trans isomers, etc.). So far, the new drug projects in charge of research have won four national new drug certificates, 2 first prizes and 3 second prizes of bureau-level achievements. He is also a member of the National Pharmacopoeia Committee, an NMPA new drug evaluation expert, a member of the NMPA drug consistency evaluation expert group, a member of the National Health and Family Planning Commission's Rational Drug Use Expert Committee, and a national major new drug evaluation expert.